gemcitabine has been researched along with Cardiovascular Stroke in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Gürses, E; Kemal, HS; Kültürsay, H; Özbay, B; Şimşek, E | 1 |
Apolo, AB; Bajorin, DF; Furberg, HF; Ostrovnaya, I; Regazzi, AM; Rosenberg, JE; Tully, CM; Zabor, EC | 1 |
Funazaki, T; Nagasaki, N; Naitoh, N; Shiba, M; Watanabe, S | 1 |
Büchler, MW; Jäger, D; Märten, A; Mühlradt, PF; Schmidt, J; Welsch, T | 1 |
Kalapura, T; Krishnamurthy, M; Reddy, CV | 1 |
Bouafia, F; Bourgeois, E; Coiffier, B; Dumontet, C; Hequet, O; Leleu, X; Morschhauser, F; Salles, G; Solal-Celigny, P; Thieblemont, C | 1 |
2 trial(s) available for gemcitabine and Cardiovascular Stroke
Article | Year |
---|---|
Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Combined Modality Therapy; Cytokines; Cytotoxicity, Immunologic; Deoxycytidine; Female; Gemcitabine; Granzymes; Humans; Injections, Intralesional; Killer Cells, Natural; Lipopeptides; Male; Middle Aged; Myocardial Infarction; Oligopeptides; Pancreatic Neoplasms; Survival Analysis; Time Factors; Toll-Like Receptor 2; Toll-Like Receptor 6; Treatment Outcome | 2007 |
Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antimetabolites; Capillary Leak Syndrome; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Fever; Gemcitabine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukopenia; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Myocardial Infarction; Pulmonary Veno-Occlusive Disease; Recurrence; Renal Insufficiency; Survival Rate; Thrombocytopenia; Time Factors | 2001 |
4 other study(ies) available for gemcitabine and Cardiovascular Stroke
Article | Year |
---|---|
Takotsubo syndrome early after treatment due to non cardiotoxic chemotherapy agents.
Topics: Aged; Antineoplastic Agents; Carcinoma; Cardiotoxicity; Deoxycytidine; Echocardiography; Electrocardiography; Female; Gemcitabine; Humans; Kidney Neoplasms; Myocardial Infarction; Takotsubo Cardiomyopathy; Vinorelbine | 2021 |
The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Carcinoma, Transitional Cell; Case-Control Studies; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Incidence; Kidney Neoplasms; Kidney Pelvis; Logistic Models; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Retrospective Studies; Stroke; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Venous Thromboembolism | 2016 |
[Acute myocardial infarction induced by lung cancer chemotherapy after radiation of left lung].
Topics: Angioplasty, Balloon, Coronary; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Myocardial Infarction | 2005 |
Acute myocardial infarction following gemcitabine therapy--a case report.
Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Electrocardiography; Gemcitabine; Humans; Male; Middle Aged; Myocardial Infarction; Pancreatic Neoplasms | 1999 |